Home › Funds › BROOKTREE CAPITAL MANAGEMENT › ABBV

BROOKTREE CAPITAL MANAGEMENT position in ABBV

ABBVIE INC · Health Care

BROOKTREE CAPITAL MANAGEMENT reported holding 4,945 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.89% of its reported portfolio and ranking #22 among its reported holdings. BROOKTREE CAPITAL MANAGEMENT has disclosed ABBV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.95K sh
Reported value held$1.29M
Portfolio Weight0.89%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BROOKTREE CAPITAL MANAGEMENT's ABBV position evolved

BROOKTREE CAPITAL MANAGEMENT first disclosed a stake in ABBV in Q3 2023 at 4,753 shares (US$708K). The position peaked in Q3 2026 at 4,945 shares, worth US$1.3M. Across 11 filings, BROOKTREE CAPITAL MANAGEMENT increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 4,945 shares valued at US$1.3M. Notable position changes include a 76% trim in Q1 2024 (shares fell 5% over the following quarter), a 369% increase in Q2 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.75K $708.48K New
Q4 2023 4.65K $720.15K Reduce
Q1 2024 1.13K $205.77K Reduce
Q3 2024 1.09K $215.45K New
Q1 2025 1.06K $221.67K New
Q2 2025 4.96K $920.30K Add
Q3 2025 4.96K $1.15M Hold
Q4 2025 4.96K $1.13M Hold
Q1 2026 4.96K $1.08M Hold
Q2 2026 4.95K $1.24M Hold
Q3 2026 4.95K $1.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has BROOKTREE CAPITAL MANAGEMENT held ABBV?

BROOKTREE CAPITAL MANAGEMENT has disclosed ABBV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is BROOKTREE CAPITAL MANAGEMENT's current position in ABBV?

As of Q3 2026, BROOKTREE CAPITAL MANAGEMENT holds 4.95K shares of ABBV (ABBVIE INC), valued at $1.29M, representing 0.89% of its reported portfolio and ranking #22.

Has BROOKTREE CAPITAL MANAGEMENT been buying or selling ABBV?

In the latest 13F filing (Q3 2026), BROOKTREE CAPITAL MANAGEMENT held unchanged its position in ABBV. The position peaked in Q3 2026 at 4.95K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.